Found: 13
Select item for more details and to access through your institution.
Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Facial nerve vulnerability in spinal muscular atrophy and motor unit number index of the orbicularis oculi muscle.
- Published in:
- Muscle & Nerve, 2023, v. 67, n. 5, p. 401, doi. 10.1002/mus.27809
- By:
- Publication type:
- Article
Assessing Prevalence and Characteristics of Oro-bulbar Involvement in Children and Adults with SMA Type 2 and 3 Using a Multimodal Approach.
- Published in:
- Dysphagia (0179051X), 2023, v. 38, n. 6, p. 1568, doi. 10.1007/s00455-023-10584-z
- By:
- Publication type:
- Article
12‐Month progression of motor and functional outcomes in congenital myotonic dystrophy.
- Published in:
- Muscle & Nerve, 2021, v. 63, n. 3, p. 384, doi. 10.1002/mus.27147
- By:
- Publication type:
- Article
Resolution of skin necrosis after nusinersen treatment in an infant with spinal muscular atrophy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association between Reported Sleep Disorders and Behavioral Issues in Children with Myotonic Dystrophy Type 1—Results from a Retrospective Analysis in Italy.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5459, doi. 10.3390/jcm13185459
- By:
- Publication type:
- Article
Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 3, p. 404, doi. 10.1002/acn3.51514
- By:
- Publication type:
- Article
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 8, p. 1622, doi. 10.1002/acn3.51411
- By:
- Publication type:
- Article
Type I SMA "new natural history": long‐term data in nusinersen‐treated patients.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 3, p. 548, doi. 10.1002/acn3.51276
- By:
- Publication type:
- Article
Respiratory function and therapeutic expectations in DMD: families experience and perspective.
- Published in:
- Acta Myologica, 2020, v. 39, n. 3, p. 121, doi. 10.36185-2532-1900-016
- By:
- Publication type:
- Article
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 8, p. 1, doi. 10.1111/ene.16309
- By:
- Publication type:
- Article
Type I spinal muscular atrophy patients treated with nusinersen: 4‐year follow‐up of motor, respiratory and bulbar function.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 6, p. 1755, doi. 10.1111/ene.15768
- By:
- Publication type:
- Article